Latest MS research news

Latest MS research news | 14 January 2014

Colour vision impairment is associated with disease severity in multiple sclerosis

This study showed that impaired colour in the eyes of MS patients who have not previously suffered optic neuritis is associated with increased clinical disability.

From MSIF

Latest MS research news | 14 January 2014

Postpartum relapses increase the risk of disability progression in MS: the role of disease modifying drugs

This study found that patients with higher disability at conception and higher relapse rate pre-pregnancy and during pregnancy were at a higher risk of relapse post-delivery.

From MSIF

Latest MS research news | 07 January 2014

Reduced sick leave in multiple sclerosis after one year of natalizumab treatment

This study group looked at the amount of sick leave in subjects with relapsing remitting MS (RRMS) before and one year after treatment with natalizumab (Tysabri).

From MSIF

Latest MS research news | 07 January 2014

Hemodynamic evidence linking cognitive deficits in clinically isolated syndrome to brain inflammation

This study looked at changes in cerebral blood flow and volume on MRI in subjects with a clinically isolated syndrome, and the relationship between these changes on MRI and memory function.

From MSIF

Latest MS research news | 07 January 2014

Effect of daclizumab high-yield process in patients with highly active relapsing-remitting MS

This analysis looked at the effects of DAC in patients with highly active RRMS and those with less active RRMS. There was no evidence that disease activity at baseline modified the effect of DAC on MS activity as treatment effects were similar in both subgroups.

From MSIF

Latest MS research news | 17 December 2013

Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion

The researchers in this study looked at changes in diffusion parameters on MRI in MS subjects during the acute phase of MS relapses and the associated changes in the cell count in the cerebrospinal fluid (CSF).

From MSIF

Latest MS research news | 17 December 2013

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease

Patients with IBD have an increased risk of developing MS and MS patients have an increased risk of developing IBD. This study showed that patients with MS and IBD appear to have a milder MS disease course without any influence on IBD course.

From MSIF

Latest MS research news | 17 December 2013

Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla

This study looked at a new MRI technique on the new high powered MRI scanner (7 Tesla), and investigated if this new technique helped to differentiate MS lesions from vascular lesions in the brain.

From MSIF

Latest MS research news | 11 December 2013

Long-term effects of dalfampridine in patients with multiple sclerosis

This study looked at the short and long term effects of treatment with dalfampridine on motor and cognitive measures in MS patients over a nine to 12 month period.

From MSIF

Latest MS research news | 11 December 2013

Smokers run increased risk of developing anti-natalizumab antibodies

This study showed that smoking during or close to the time of treatment with natalizumab (Tysabri) was associated with an increased risk of developing antibodies against natalizumab.

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research